Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to study the efficacy and safety of naltrexone implants
as a relapse prevention for opiate addicted inmates about to be released from prison. The
experimental group is compared with a control group that commences methadone maintenance
treatment before release.
The hypothesises are that quality of life and criminal behaviour improve significantly in
both groups compared to the month before incarceration. The experimental group is going to
have significant less days with opioid use compared to the MMT group.
We hypothesize furthermore that the implants can prevent death related to opiate overdose up
to 6 months after commenced treatment.